Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
Top Cited Papers
- 1 January 2016
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 69 (1), 9-12
- https://doi.org/10.1016/j.eururo.2015.07.004
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the LiteratureEuropean Urology, 2015
- Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrenceRadiation Oncology, 2014
- Long-term Outcomes of Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer: Results of a Single-institution Series with a Minimum Follow-up of 5 YearsEuropean Urology, 2014
- Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancerUrologic Oncology, 2013
- Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastasesActa Oncologica, 2013
- Stereotactic body radiotherapy for oligometastasesThe Lancet Oncology, 2012
- Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate CancerInternational Journal of Radiation Oncology*Biology*Physics, 2012
- 21 years of Biologically Effective DoseThe British Journal of Radiology, 2010
- American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2010
- The Natural History of Noncastrate Metastatic Prostate Cancer after Radical ProstatectomyEuropean Urology, 2007